{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:48:29Z","timestamp":1791143309201,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,6,14]],"date-time":"2010-06-14T00:00:00Z","timestamp":1276473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2010,6,14]],"date-time":"2010-06-14T00:00:00Z","timestamp":1276473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"Abstract<\/jats:title>\n Introduction<\/jats:title>\n The objective of the present study was to analyse secular trends in antibiotic consumption and resistance data from a network of 53 intensive care units (ICUs).<\/jats:p>\n <\/jats:sec>\n Methods<\/jats:title>\n The study involved prospective unit and laboratory-based surveillance in 53 German ICUs from 2001 through 2008. Data were calculated on the basis of proportions of nonduplicate resistant isolates, resistance densities (that is, the number of resistant isolates of a species per 1,000 patient-days) and an antimicrobial usage density (AD) expressed as daily defined doses (DDD) and normalised per 1,000 patient-days.<\/jats:p>\n <\/jats:sec>\n Results<\/jats:title>\n Total mean antibiotic use remained stable over time and amounted to 1,172 DDD\/1,000 patient-days (range 531 to 2,471). Carbapenem use almost doubled to an AD of 151 in 2008. Significant increases were also calculated for quinolone (AD of 163 in 2008) and third-generation and fourth-generation cephalosporin use (AD of 117 in 2008). Aminoglycoside consumption decreased substantially (AD of 86 in 2001 and 24 in 2008). Resistance proportions were as follows in 2001 and 2008, respectively: methicillin-resistant Staphylococcus aureus<\/jats:italic> (MRSA) 26% and 20% (P<\/jats:italic> = 0.006; trend test showed a significant decrease), vancomycin-resistant enterococcus (VRE) faecium<\/jats:italic> 2.3% and 8.2% (P<\/jats:italic> = 0.008), third-generation cephalosporin (3GC)-resistant Escherichia<\/jats:italic>. coli<\/jats:italic> 1.2% and 19.7% (P<\/jats:italic> < 0.001), 3GC-resistant Klebsiella pneumoniae<\/jats:italic> 3.8% and 25.5% (P<\/jats:italic> < 0.001), imipenem-resistant Acinetobacter baumannii<\/jats:italic> 1.1% and 4.5% (P<\/jats:italic> = 0.002), and imipenem-resistant K. pneumoniae<\/jats:italic> 0.4% and 1.1%. The resistance densities did not change for MRSA but increased significantly for VRE faecium<\/jats:italic> and 3GC-resistant E. coli<\/jats:italic> and K. pneumoniae<\/jats:italic>. In 2008, the resistance density for MRSA was 3.73, 0.48 for VRE, 1.39 for 3GC-resistant E. coli<\/jats:italic> and 0.82 for K. pneumoniae<\/jats:italic>.<\/jats:p>\n <\/jats:sec>\n Conclusions<\/jats:title>\n Although total antibiotic use did not change over time in German ICUs, carbapenem use doubled. This is probably due to the rise in 3GC-resistant E. coli<\/jats:italic> and K. pneumoniae<\/jats:italic>. Increased carbapenem consumption was associated with carbapenem-resistant K. pneumoniae<\/jats:italic> carbapenemase-producing bacteria and imipenem-resistant A. baumannii<\/jats:italic>.<\/jats:p>\n <\/jats:sec>","DOI":"10.1186\/cc9062","type":"journal-article","created":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T06:14:38Z","timestamp":1276582478000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":158,"title":["Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008"],"prefix":"10.1186","volume":"14","author":[{"given":"Elisabeth","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Schroeren-Boersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Gastmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,14]]},"reference":[{"key":"8491_CR1","unstructured":"WHO Global Strategy for Containment of Antimicrobial Resistance[http:\/\/www.who.int\/drugresistance\/WHO_Global_Strategy_English.pdf]"},{"key":"8491_CR2","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1086\/344654","volume":"36","author":"DM Livermore","year":"2003","unstructured":"Livermore DM: Bacterial resistance: origins, epidemiology, and impact.\n Clin Infect Dis 2003, 36: S11-S23. 10.1086\/344654","journal-title":"Clin Infect Dis"},{"key":"8491_CR3","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1371\/journal.pmed.0030029","volume":"3","author":"KR Foster","year":"2006","unstructured":"Foster KR, Grundmann H: Do we need to put society first? The potential for tragedy in antimicrobial resistance.\n PLoS Med 2006, 3: e29. 10.1371\/journal.pmed.0030029","journal-title":"PLoS Med"},{"key":"8491_CR4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1586\/14787210.6.5.751","volume":"6","author":"LL Maragakis","year":"2008","unstructured":"Maragakis LL, Perencevich EN, Cosgrove SE: Clinical and economic burden of antimicrobial resistance.\n Expert Rev Anti Infect Ther 2008, 6: 751-763. 10.1586\/14787210.6.5.751","journal-title":"Expert Rev Anti Infect Ther"},{"key":"8491_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3201\/eid0803.010192","volume":"8","author":"SL Bronzwaer","year":"2002","unstructured":"Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK, Kool JL, Sprenger MJ, Degener JE: A European study on the relationship between antimicrobial use and antimicrobial resistance.\n Emerg Infect Dis 2002, 8: 278-282. 10.3201\/eid0803.010192","journal-title":"Emerg Infect Dis"},{"key":"8491_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1476-0711-3-14","volume":"3","author":"ME Jones","year":"2004","unstructured":"Jones ME, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, Wenzel RP: Emerging resistance among bacterial pathogens in the intensive care unit - a European and North American Surveillance study (2000-2002).\n Ann Clin Microbiol Antimicrob 2004, 3: 14. 10.1186\/1476-0711-3-14","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"8491_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1473-3099(08)70017-3","volume":"8","author":"S Molstad","year":"2008","unstructured":"Molstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, Lundborg CS, Soderstrom A, Torell E, Cars O: Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme.\n Lancet Infect Dis 2008, 8: 125-132. 10.1016\/S1473-3099(08)70017-3","journal-title":"Lancet Infect Dis"},{"key":"8491_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/jac\/dkl147","volume":"58","author":"RH Vander Stichele","year":"2006","unstructured":"Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H: Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002).\n J Antimicrob Chemother 2006, 58: 159-167. 10.1093\/jac\/dkl147","journal-title":"J Antimicrob Chemother"},{"key":"8491_CR9","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/jac\/dkn391","volume":"62","author":"E Meyer","year":"2008","unstructured":"Meyer E, Gastmeier P, Schwab F: The burden of multiresistant bacteria in German intensive care units.\n J Antimicrob Chemother 2008, 62: 1474-1476. 10.1093\/jac\/dkn391","journal-title":"J Antimicrob Chemother"},{"key":"8491_CR10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s15010-003-3201-7","volume":"31","author":"E Meyer","year":"2003","unstructured":"Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD: Design of a surveillance system of antibiotic use and bacterial resistance in German intensive Care units (SARI).\n Infection 2003, 31: 208-215.","journal-title":"Infection"},{"key":"8491_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1086\/500619","volume":"27","author":"E Meyer","year":"2006","unstructured":"Meyer E, Schwab F, Gastmeier P, Jonas D, Rueden H, Daschner FD: Methicillin-resistant Staphylococcus aureus in German intensive care units during 2000-2003: data from project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units).\n Infect Control Hosp Epidemiol 2006, 27: 146-154. 10.1086\/500619","journal-title":"Infect Control Hosp Epidemiol"},{"key":"8491_CR12","unstructured":"Surveillance der Antibiotika-Anwendung und der bakteriellen Resistenzen auf Intensivstationen[http:\/\/www.nrz-hygiene.de\/sari\/sari.htm]"},{"key":"8491_CR13","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology ATC\/DDD Index[http:\/\/www.whocc.no\/atc_ddd_index\/]"},{"key":"8491_CR14","unstructured":"Leitlinien und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP)[http:\/\/www.rki.de\/cln_169\/nn_205212\/DE\/Content\/GBE\/EpidemiologischeMethoden\/Empfehlungen\/empfehlungen__pdf1,templateId=raw,property=publicationFile.pdf\/empfehlungen_pdf1.pdf]"},{"key":"8491_CR15","unstructured":"Gesetz zur Verh\u00fctung und Bek\u00e4mpfung von Infektionskrankheiten beim Menschen[http:\/\/bundesrecht.juris.de\/ifsg\/__23.html]"},{"key":"8491_CR16","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/jac\/dkm088","volume":"59","author":"E Meyer","year":"2007","unstructured":"Meyer E, Buttler J, Schneider C, Strehl E, Schroeren-Boersch B, Gastmeier P, Ruden H, Zentner J, Daschner FD, Schwab F: Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced.\n J Antimicrob Chemother 2007, 59: 1148-1154. 10.1093\/jac\/dkm088","journal-title":"J Antimicrob Chemother"},{"key":"8491_CR17","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s00134-008-1355-6","volume":"35","author":"E Meyer","year":"2009","unstructured":"Meyer E, Lapatschek M, Bechtold A, Schwarzkopf G, Gastmeier P, Schwab F: Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant\n K. pneumoniae\n and\n E. coli\n in an ICU.\n Intensive Care Med 2009, 35: 862-870. 10.1007\/s00134-008-1355-6","journal-title":"Intensive Care Med"},{"key":"8491_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s15010-009-9115-2","volume":"38","author":"E Meyer","year":"2010","unstructured":"Meyer E, Schwab F, Pollitt A, Bettolo W, Schroeren-Boersch B, Trautmann M: Impact of a change in antibiotic prophylaxis on total antibiotic use in a surgical intensive care unit.\n Infection 2010, 38: 19-24. 10.1007\/s15010-009-9115-2","journal-title":"Infection"},{"key":"8491_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00134-008-1237-y","volume":"35","author":"H Hanberger","year":"2009","unstructured":"Hanberger H, Arman D, Gill H, Jindrak V, Kalenic S, Kurcz A, Licker M, Naaber P, Scicluna EA, Vanis V, Hanberger H, Arman D, Gill H, Jindrak V, Kalenic S, Kurcz A, Licker M, Naaber P, Scicluna EA, Vanis V, Walther SM: Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control.\n Intensive Care Med 2009, 35: 91-100. 10.1007\/s00134-008-1237-y","journal-title":"Intensive Care Med"},{"key":"8491_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/00365540600740504","volume":"39","author":"M Erlandsson","year":"2007","unstructured":"Erlandsson M, Burman LG, Cars O, Gill H, Nilsson LE, Walther SM, Hanberger H: Prescription of antibiotic agents in Swedish intensive care units is empiric and precise.\n Scand J Infect Dis 2007, 39: 63-69. 10.1080\/00365540600740504","journal-title":"Scand J Infect Dis"},{"key":"8491_CR21","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/j.1399-6576.2007.01364.x","volume":"51","author":"H Hanberger","year":"2007","unstructured":"Hanberger H, Burman LG, Cars O, Erlandsson M, Gill H, Nilsson LE, Nordlinder D, Walther SM: Low antibiotic resistance rates in\n Staphylococcus aureus\n ,\n Escherichia coli\n and\n Klebsiella\n spp but not in\n Enterobacter\n spp and\n Pseudomonas aeruginosa\n : a prospective observational study in 14 Swedish ICUs over a 5-year period.\n Acta Anaesthesiol Scand 2007, 51: 937-941. 10.1111\/j.1399-6576.2007.01364.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"8491_CR22","unstructured":"European Antimicrobial Resistance Surveillance System annual report 2008[http:\/\/www.rivm.nl\/earss\/Images\/EARSS%202008_final_tcm61-65020.pdf]"},{"key":"8491_CR23","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3201\/eid1308.070071","volume":"13","author":"AD Harris","year":"2007","unstructured":"Harris AD, McGregor JC, Johnson JA, Strauss SM, Moore AC, Standiford HC, Hebden JN, Morris JG: Risk factors for colonization with extended-spectrum \u03b2-lactamase-producing bacteria and intensive care unit admission.\n Emerg Infect Dis 2007, 13: 1144-1149.","journal-title":"Emerg Infect Dis"},{"key":"8491_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1086\/592702","volume":"30","author":"E Meyer","year":"2009","unstructured":"Meyer E, Serr A, Schneider C, Utzolino S, Kern WV, Scholz R, Dettenkofer M: Should we screen patients for extended-spectrum \u03b2-lactamase-producing enterobacteriaceae in intensive care units?\n Infect Control Hosp Epidemiol 2009, 30: 103-105. 10.1086\/592702","journal-title":"Infect Control Hosp Epidemiol"},{"key":"8491_CR25","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1128\/JCM.42.3.1089-1094.2004","volume":"42","author":"J Rodriguez-Bano","year":"2004","unstructured":"Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, Perez-Cano R, Pascual A: Epidemiology and clinical features of infections caused by extended-spectrum \u03b2-lactamase-producing\n Escherichia coli\n in nonhospitalized patients.\n J Clin Microbiol 2004, 42: 1089-1094. 10.1128\/JCM.42.3.1089-1094.2004","journal-title":"J Clin Microbiol"},{"key":"8491_CR26","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/jac\/dkp108","volume":"63","author":"C Arpin","year":"2009","unstructured":"Arpin C, Quentin C, Grobost F, Cambau E, Robert J, Dubois V, Coulange L, Andre C: Nationwide survey of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in the French community setting.\n J Antimicrob Chemother 2009, 63: 1205-1214. 10.1093\/jac\/dkp108","journal-title":"J Antimicrob Chemother"},{"key":"8491_CR27","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1086\/604713","volume":"49","author":"R Ben-Ami","year":"2009","unstructured":"Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout JD, Quentin C, Calbo ES, Azap OK, Arpin C, Pascual A, Livermore DM, Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout JD, Quentin C, Calbo ES, Azap OK, Arpin C, Pascual A, Livermore DM, Garau J, Carmeli Y: A multinational survey of risk factors for infection with extended-spectrum \u03b2-lactamase-producing enterobacteriaceae in nonhospitalized patients.\n Clin Infect Dis 2009, 49: 682-690. 10.1086\/604713","journal-title":"Clin Infect Dis"},{"key":"8491_CR28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/jac\/dkn534","volume":"63","author":"K Kaier","year":"2009","unstructured":"Kaier K, Frank U, Hagist C, Conrad A, Meyer E: The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum beta-lactamase-producing strains: a time-series analysis.\n J Antimicrob Chemother 2009, 63: 609-614. 10.1093\/jac\/dkn534","journal-title":"J Antimicrob Chemother"},{"key":"8491_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1473-3099(09)70054-4","volume":"9","author":"P Nordmann","year":"2009","unstructured":"Nordmann P, Cuzon G, Naas T: The real threat of\n Klebsiella pneumoniae\n carbapenemase-producing bacteria.\n Lancet Infect Dis 2009, 9: 228-236. 10.1016\/S1473-3099(09)70054-4","journal-title":"Lancet Infect Dis"},{"key":"8491_CR30","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1128\/AAC.00784-09","volume":"53","author":"B Kitchel","year":"2009","unstructured":"Kitchel B, Sundin DR, Patel JB: Regional dissemination of KPC-producing\n Klebsiella pneumoniae\n .\n Antimicrob Agents Chemother 2009, 53: 4511-4513. 10.1128\/AAC.00784-09","journal-title":"Antimicrob Agents Chemother"},{"key":"8491_CR31","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1086\/429822","volume":"40","author":"T Hong","year":"2005","unstructured":"Hong T, Moland ES, Abdalhamid B, Hanson ND, Wang J, Sloan C, Fabian D, Farajallah A, Levine J, Thomson KS: Escherichia coli\n : development of carbapenem resistance during therapy.\n Clin Infect Dis 2005, 40: e84-e86. 10.1086\/429822","journal-title":"Clin Infect Dis"},{"key":"8491_CR32","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1016\/j.ajic.2007.10.006","volume":"35","author":"JD Siegel","year":"2007","unstructured":"Siegel JD, Rhinehart E, Jackson M, Chiarello L: Management of multidrug-resistant organisms in health care settings, 2006.\n Am J Infect Control 2007, 35: S165-S193. 10.1016\/j.ajic.2007.10.006","journal-title":"Am J Infect Control"},{"key":"8491_CR33","unstructured":"Kresken M, Hafner D, Schmitz FJ, Wichelhaus TA: Resistenzsituation bei klinisch wichtigen Infektionserregern gegen\u00fcber Antibiotika in Deutschland und im mitteleurop,,ischen Raum.[http:\/\/www.p-e-g.org\/ag_resistenz\/main.htm]"},{"key":"8491_CR34","unstructured":"GERMAP 2008 Antibiotika-Resistenz und -Verbrauch[http:\/\/www.bvl.bund.de\/cln_007\/DE\/08__PresseInfothek\/00__doks__downloads\/Germap__2008,templateId=raw,property=publicationFile.pdf\/Germap_2008.pdf]"},{"key":"8491_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/jac\/dkp428","volume":"65","author":"DC Higgins PG","year":"2010","unstructured":"Higgins PG DC, Hackel M, Seifert H: Global spread of carbapenem-resistant\n Acinetobacter baumannii\n .\n J Antimicrob Chemother 2010, 65: 233-238. 10.1093\/jac\/dkp428","journal-title":"J Antimicrob Chemother"},{"key":"8491_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s15010-008-8138-4","volume":"37","author":"K de With","year":"2009","unstructured":"de With K, Bestehorn H, Steib-Bauert M, Kern WV: Comparison of defined versus recommended versus prescribed daily doses for measuring hospital antibiotic consumption.\n Infection 2009, 37: 349-352. 10.1007\/s15010-008-8138-4","journal-title":"Infection"},{"key":"8491_CR37","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1365-2125.2006.02605.x","volume":"61","author":"A Muller","year":"2006","unstructured":"Muller A, Monnet DL, Talon D, Henon T, Bertrand X: Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital.\n Br J Clin Pharmacol 2006, 61: 585-591. 10.1111\/j.1365-2125.2006.02605.x","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 1","key":"8491_CR38","doi-asserted-by":"publisher","first-page":"i29","DOI":"10.1093\/jac\/dkp255","volume":"64","author":"DM Livermore","year":"2009","unstructured":"Livermore DM: Has the era of untreatable infections arrived?\n J Antimicrob Chemother 2009,64(Suppl 1):i29-i36. 10.1093\/jac\/dkp255","journal-title":"J Antimicrob Chemother"},{"key":"8491_CR39","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1128\/JCM.01314-09","volume":"47","author":"A Tsakris","year":"2009","unstructured":"Tsakris A, Poulou A, Themeli-Digalaki K, Voulgari E, Pittaras T, Sofianou D, Pournaras S, Petropoulou D: Use of boronic acid disk tests to detect extended-spectrum \u03b2-lactamases in KPC carbapenemase-possessing enterobacteriaceae clinical isolates.\n J Clin Microbiol 2009, 47: 3420-3426. 10.1128\/JCM.01314-09","journal-title":"J Clin Microbiol"},{"key":"8491_CR40","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","volume":"290","author":"J Chastre","year":"2003","unstructured":"Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S: Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.\n JAMA 2003, 290: 2588-2598. 10.1001\/jama.290.19.2588","journal-title":"JAMA"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc9062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc9062\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc9062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:12:43Z","timestamp":1728303163000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc9062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,14]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,6]]}},"alternative-id":["8491"],"URL":"https:\/\/doi.org\/10.1186\/cc9062","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,14]]},"assertion":[{"value":"23 October 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R113"}}